Background There is widespread, increasing use of magnesium sulphate in obstetric
practice for pre-eclampsia, eclampsia, and preterm fetal neuroprotection; benefit for …

Please cite this paper as: Huusom L, Secher N, Pryds O, Whitfield K, Gluud C, Brok J.
Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants—but are we …

Objective: To provide guidelines for the use of antenatal magnesium sulphate (MgSO4) for
fetal neuroprotection of the preterm infant. Options: Antenatal MgSO4 administration should …

Objective To evaluate whether magnesium sulphate (MgSO4) given to women at risk of very‐
preterm birth would be neuroprotective in preterm newborns and would prevent neonatal …

We conducted a systematic review and metaanalysis of randomized controlled trials to
determine whether magnesium sulfate administered to women at risk of preterm delivery …

Background Magnesium sulphate has been used in some settings as a tocolytic agent to
inhibit uterine activity in women in preterm labour with the aim of preventing preterm birth …

[Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm
newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective …

High-dosage, tocolytic magnesium sulfate (MgSO 4) administered to pregnant women
during preterm labor can be toxic, and sometimes lethal, for their newborns (Cochrane …

Importance Intravenous magnesium sulfate administered to pregnant individuals before birth
at less than 30 weeks' gestation reduces the risk of death and cerebral palsy in their …

Very preterm infants have high rates of neurological impairments and disabilities. These
rates have not diminished as the survival rates have improved. Basic science research …